Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Brescia
Clinical trial register · Italy

Clinical Trials in Brescia, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6778 matching records held by the registry are in this view. Synced 08 Oct 2026, 03:19 UTC
6778
Studies in scope
all four open statuses
4069
Recruiting now
open to new participants
1018
Lead sponsors
across recruiting studies
Top sites
Milan 2843 Bologna 1305 Roma 1274 Naples 984 Rome 967
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca27 Fondazione Italiana Linfomi - ETS25 Novartis Pharmaceuticals21 Hoffmann-La Roche18 Merck Sharp & Dohme LLC16
Site location
Milan2843 Bologna1305 Roma1274 Naples984 Rome967
All 489 locations
Target enrolment
to

Trials with a site in Brescia

522 of 6778 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Not yet open
Chiesi Farmaceutici S.p.A.
Phase 3
700
Brescia, Brindisi, Genoa, Messina, Milan, Naples, Parma, Pisa
2026-11-16
Not yet open
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2
158
Brescia, Milan, Roma, Udine
2026-11
Not yet open
Endoscopic Management of Biliopancreatic Disease in the Lombardy Pancreas Units
NCT07418164Pancreatic Cancer, Biliopancreatic Diseases, Periampullary Neoplasms
IRCCS San Raffaele
Observational
2,500
Bergamo, Brescia, Cremona, Legnano, Mantua, Milan, Monza, Pavia
2026-10-31
Not yet open
Fondazione Italiana Linfomi - ETS
Observational
1,000
Candiolo, Castelfranco Veneto, Alessandria, Aviano, Bari, Bergamo, Bologna, Brescia
2026-10
Not yet open
Fondazione EMN Italy Onlus
Observational
92
Bari, Bologna, Brescia, Castelfranco Veneto, Como, Milan, Novara, Pavia
2026-10
Not yet open
Bristol-Myers Squibb
Phase 3
850
Meldola, Candiolo, Bergamo, Brescia, Milan, Pavia, Verona
2026-09-30
Recruiting
Transcranial Alternating Current Stimulation (tACS) Combined With Cognitive Training in Alzheimer's Disease
NCT07839650Transcranial Alternating Current Stimulation, Alzheimer Disease (AD), Alzheimer Dementia (AD), Cognitive Rehabilitation
IRCCS Centro San Giovanni di Dio Fatebenefratelli
Not applicable
30
Brescia, Milan
2026-09-16
Recruiting
CSL Behring
Phase 3
63
Rome, Brescia, Varese, Candiolo, Catania, Florence, Milan
2026-09-15
Not yet open
Italian Validation of the dNA Scale and Its Correlation With Neurocognitive Variables
NCT07533084Active Aging Individuals Aged 65 and Over, Aging, Mild Cognitive Impairment (MCI), Dementia
Neuromed IRCCS
Observational
265
Brescia, Genova, Pozzilli, Milan, Pavia, Roma, Venezia
2026-09
Recruiting
AstraZeneca
Phase 3
1,072
Brescia, Cona, Florence, Milan, Roma
2026-08-31
Recruiting
IRCCS Centro San Giovanni di Dio Fatebenefratelli
Not applicable
42
Brescia
2026-08-26
Recruiting
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
NCT07761117Heart Failure With Preserved Ejection Fraction (HFpEF), Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF)
DrugElecoglipron
AstraZeneca
Phase 3
6,950
Ancona, Bergamo, Brescia, Milan, Pavia, Perugia, Riccione, Salerno
2026-08-24
Recruiting
Fondazione Italiana Linfomi - ETS
Phase 3
518
Alessandria, Avellino, Aviano, Bergamo, Brescia, Cagliari, Candiolo, Catania
2026-07-10
Not yet open
VIPPSTAR-G1 Digital Early Intervention for Visual Impairment
NCT07717671Visual Impairment, Cerebral Visual Impairment, Neurodevelopmental Disorders, Prematurity
Università degli Studi di Brescia
Not applicable
150
Brescia, Pavia
2026-07-01
Recruiting
Digital Solutions for Predicting the Biological Mechanisms of Alzheimer's Disease Through the Analysis of Risk Factors
NCT07731191Mild Cognitive Impairment (MCI), Subjective Cognitive Decline (SCD)
IRCCS Centro San Giovanni di Dio Fatebenefratelli
Not applicable
240
Brescia
2026-06-24
Recruiting
Ono Pharmaceutical Co., Ltd.
Phase 3
132
Brescia, Meldola, Reggio Emilia
2026-06-12
Recruiting
Fondazione Italiana Linfomi - ETS
Phase 2
41
Alessandria, Bologna, Brescia, Florence, Genova, Milan, Palermo, Pescara
2026-06-05
Recruiting
Hoffmann-La Roche
Phase 2
30
Rome, Brescia, Rozzano
2026-05-25
Recruiting
Novo Nordisk A/S
Phase 3
2,500
Bologna, Genoa, Brescia, Milan, Perugia, Messina, Ancorna, Pisa
2026-05-21
Recruiting
Hoffmann-La Roche
Phase 2/3
650
Naples, Meldola, Parma, Aviano, Rome, Bergamo, Brescia, Milan
2026-05-21
Recruiting
Novartis Pharmaceuticals
Phase 3
5,700
Ancona, Bergamo, Bologna, Brescia, Cona, Florence, Pozzilli, Milan
2026-05-11
Active, closed
Observational Study on Eltrombopag in Hypocellular Myelodysplastic Neoplasms
NCT07825207Myelodysplastic Neoplasm, Myelodysplastic Syndrome
DrugEltrombopag
Fondazione Italiana Sindromi Mielodisplastiche-ETS
Observational
100
Alessandria, Bari, Bologna, Brescia, Candiolo, Florence, Genova, Mantua
2026-05-01
Not yet open
Fondazione Italiana Linfomi - ETS
Not applicable
170
Ancona, Avellino, Aviano, Bari, Brescia, Cagliari, Florence, Milan
2026-05
Not yet open
Neurocognitive Assessment in Adults Undergoing CD19 Targeted CAR-T Cell Therapy
NCT07463781Diffuse Large B Cell Lymphoma (DLBCL), High Grade B Cell Lymphoma, Primary Mediastinal B-cell Lymphoma (PMBCL)
Fondazione Italiana Linfomi - ETS
Observational
100
Alessandria, Ancona, Brescia, Palermo, Reggio Calabria, Roma, Taranto, Udine
2026-05
Recruiting
Visugromab in Cachexia International Trial
NCT07112196Cancer-associated Cachexia
DrugVisugromab
CatalYm GmbH
Phase 2/3
518
Aviano, Brescia, Ferrara, Meldola, Verona
2026-04-16
Recruiting
AstraZeneca
Phase 3
245
Brescia, Catania, Ferrara, Florence, Milan, Padova, Pisa, Roma
2026-04-13
Recruiting
Incyte Corporation
Phase 3
588
Bologna, Brescia, Candiolo, Foggia, Milan, Naples, Pisa, Roma
2026-04-09
Recruiting
Mastelli S.r.l
Not applicable
40
Brescia
2026-04-02
Recruiting
AstraZeneca
Phase 2
43
Brescia, Rozzano, Torino, Verona
2026-03-28
Recruiting
A Study to Assess the Effects of Zigakibart on IgA Nephropathy.
NCT07146906Immunoglobulin A Nephropathy (IgAN)
DrugZigakibart
Novartis Pharmaceuticals
Phase 2
32
Ranica, Brescia, Pavia
2026-03-26
Recruiting
Novartis Pharmaceuticals
Phase 3
770
Bologna, Brescia, Milan
2026-03-24
Recruiting
Liaquat University of Medical & Health Sciences
Not applicable
132
Forlì, Ravenna, Rome, Brescia, Pavia, Turin, Catania, Florence
2026-03-23
Recruiting
Sanofi
Phase 2/3
526
Torette, Milan, Rome, Bologna, Brescia, Novara
2026-03-13
Recruiting
Incyte Corporation
Phase 3
700
Ancona, Aviano, Bari, Brescia, Candiolo, Catania, Milan, Naples
2026-03-05
Recruiting
IRCCS Centro San Giovanni di Dio Fatebenefratelli
Not applicable
84
Brescia
2026-03-01
Not yet open
Humanitas Hospital, Italy
Observational
226
Milan, Brescia, Roma
2026-03
Not yet open
Universitat Internacional de Catalunya
Observational
90
Brescia
2026-03
Recruiting
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
Observational
1,941
Brescia
2026-02-20
Recruiting
Neurological Events and Unforeseen Risks After Locoregional-anesthesia
NCT07238933Regional Anesthesia, Regional Anesthesia Block
Societa Italiana Anestesia Analgesia Rianimazione e Terapia Intensiva
Observational
3,396
Bergamo, Brescia, Rozzano, Padova
2026-02-18
Recruiting
Merck Sharp & Dohme LLC
Phase 3
900
Brescia, Lecco, Milan, Padova, Roma, Torino
2026-02-16
Recruiting
ImmunAbs Inc.
Phase 1/2
96
Brescia, Milan
2026-02-05
Recruiting
Meyer Children's Hospital IRCCS
Observational
500
Florence, Bergamo, Brescia, Catania, Lecce, Modena, Novara, Padova
2026-02-05
Recruiting
Janssen Research & Development, LLC
Phase 3
400
Alessandria, Brescia, Milan, Pisa, Reggio Emilia, Roma, Rozzano, San Giovanni Rotondo
2026-02-04
Recruiting
Transcranial Alternating Current Stimulation in Frontotemporal Dementia
NCT07505784Transcranial Alternating Current Stimulation, Frontotemporal Dementia (FTD)
IRCCS Centro San Giovanni di Dio Fatebenefratelli
Not applicable
30
Brescia
2026-02-03
Recruiting
Exciva GmbH
Phase 2/3
300
Rome, Tricase, Brescia, Milan, Palermo
2026-02-02
Not yet open
Fondazione Italiana Linfomi - ETS
Phase 2
56
Meldola, Rozzano, Ancona, Avellino, Biella, Bologna, Brescia, Catania
2026-02-01
Not yet open
Gruppo Oncologico Italiano di Ricerca Clinica
Phase 2
270
Arezzo, Aviano, Bologna, Brescia, Catania, Cuneo, Florence, Genova
2026-01-31
Recruiting
Generate Biomedicines
Phase 3
786
Trieste, Brescia
2026-01-20
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,023
Meldola, Aviano, Milan, Brescia, Catania, Padova, Roma, Torino
2026-01-19
Recruiting
IRCCS Centro San Giovanni di Dio Fatebenefratelli
Not applicable
72
Brescia, Milan
2026-01-15
Recruiting
Novartis Pharmaceuticals
Observational
50
Alessandria, Avellino, Brescia, Florence, Genova, Milan, Palermo, Roma
2026-01-13
Recruiting
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
NCT07222566Advanced Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC)
DrugsPF-08634404·Pembrolizumab
Pfizer
Phase 3
1,410
Naples, Misterbianco, Meldola, Milan, Fano, Aviano, Roma, Brescia
2026-01-06
Recruiting
AstraZeneca
Observational
218
Monserrato, Cona, San Giovanni Rotondo, Rozzano, Ancona, Bari, Brescia, Florence
2025-12-31
Recruiting
AstraZeneca
Phase 3
1,100
Brescia, Catania, Florence, Lecco, Milan, Naples, Parma, Pisa
2025-12-29
Recruiting
Sanofi
Phase 2
144
Torette, Cona, Garbagnate Milanese, Milan, Brescia, Chieti, Pisa
2025-12-29
Recruiting
Incyte Corporation
Phase 2
56
Bologna, Brescia, Meldola, Milan, Naples, Padova, Roma
2025-12-29
Recruiting
Novartis Pharmaceuticals
Observational
250
Ancona, Bari, Brescia, Cona, Florence, Genova, Lecce, Messina
2025-12-17
Recruiting
Janssen Research & Development, LLC
Observational
200
Bari, Brescia, Iesi, Milan, Naples, Palermo, Pavia, Perugia
2025-12-04
Recruiting
Janssen Research & Development, LLC
Observational
380
Avellino, Aviano, Bari, Bergamo, Brescia, Candiolo, Catania, Catanzaro
2025-12-03
Recruiting
Bristol-Myers Squibb
Phase 3
650
Naples, Rome, Milan, Pisa, Brescia, Isernia, Roma
2025-12-02
Recruiting
A ELN-Multicenter Study on Phenotypic Evolution and Clinical Outcomes
NCT07203768Polycythemia Vera, Thrombocythemia
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS
Observational
678
Pavia, Vicenza, Alessandria, Bergamo, Bologna, Brescia, Florence, Milan
2025-12-01
Recruiting
Eli Lilly and Company
Phase 3
7,140
Bologna, Brescia, Ferrara, Florence, Genova, Milan, Monza, Palermo
2025-12-01
Not yet open
University Hospital Tuebingen
Phase 2
120
Brescia, Milan
2025-12
Recruiting
Alexion Pharmaceuticals, Inc.
Phase 2
75
Brescia, Padova, Pavia, Pisa
2025-11-26
Recruiting
Syndax Pharmaceuticals
Phase 3
468
Monza, Pesaro, Alessandria, Bergamo, Bologna, Brescia, Candiolo, Florence
2025-11-25
Recruiting
Hoffmann-La Roche
Phase 3
900
Naples, Salerno, Bologna, Cassino, Rome, Genoa, Brescia, Milan
2025-11-24
Active, closed
Bayer
Phase 2
60
Bologna, Brescia, Genova, Roma
2025-11-19
Recruiting
Summit Therapeutics
Phase 3
600
Roma, Aviano, Brescia, Florence, Genova, Meldola, Milan, Pisa
2025-11-18
Recruiting
UCB Biopharma SRL
Phase 3
320
Brescia, Roma, Rozzano
2025-11-14
Recruiting
Incyte Corporation
Phase 3
250
Bologna, Brescia, Catania, Milan, Naples, Padua, Roma, Rome
2025-11-13
Recruiting
Boehringer Ingelheim
Phase 3
670
Aviano (PN), Bari, Brescia, Florence, Meldola (FC), Orbassano (TO), Padova, Parma
2025-11-07
Recruiting
Takeda
Phase 2
200
Rozzano, Rome, Brescia, Florence
2025-11-03
Recruiting
A Non-interventional Study of Participants With BPDCN Treated With Chemotherapy
NCT07785180Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Stemline Therapeutics, Inc.
Observational
140
Alessandria, Bari, Bologna, Brescia, Catania, Florence, Milan, Naples
2025-10-17
Active, closed
A New Crowding Indicator in the Emergency Department
NCT07111624Emergency Department, Crowding
Mario Negri Institute for Pharmacological Research
Observational
828
Brescia, Genova, Ravenna, Roma, Cirié, Orbassano, Vercelli, Alessandria
2025-10-15
Recruiting
Bristol-Myers Squibb
Observational
223
Ferrara, Torino, Brescia
2025-10-08
Recruiting
Genentech, Inc.
Phase 1/2
285
Bologna, Meldola, Bergamo, Brescia, Milan
2025-10-07
Recruiting
Novo Nordisk A/S
Phase 3
1,280
Ancona - Torrette, Bologna, Bolzano, Brescia, Cona, Florence, Ivrea, Lecco
2025-10-02
Recruiting
University of Campania Luigi Vanvitelli
Phase 3
480
Ancona, Avellino, Aviano, Bari, Brescia, Castellana Grotte, Catania, Catanzaro
2025-10-01
Recruiting
Lifestyle Interventions to Prevent Cognitive Deficits in Subjects With Depressive Symptoms: From Mechanisms to Clinical Practice
NCT07009223Major Depressive Disorder (MDD), Physical Activity, Inflammation, Metabolome
IRCCS Centro San Giovanni di Dio Fatebenefratelli
Not applicable
120
Brescia
2025-10-01
Recruiting
Transcranial Alternating Current Stimulation in Lewy Body Dementia
NCT07375771Lewy Body Dementia (LBD), Transcranial Alternating Current Stimulation
IRCCS Centro San Giovanni di Dio Fatebenefratelli
Not applicable
40
Brescia, Trieste
2025-10-01
Recruiting
European Institute of Oncology
Observational
750
Bergamo, Brescia, Brindisi, Crema, Lecco, Legnano, Milan, Modena
2025-09-29
Recruiting
Genentech, Inc.
Phase 2
224
Rome, Brescia, Milan, Rho, Rozzano, San Donato Milanese (MI), Turin, Negrar
2025-09-29
Recruiting
Kura Oncology, Inc.
Phase 3
1,300
Bologna, Ravenna, Trieste, Brescia, Ascoli Piceno, Perugia
2025-09-26
Recruiting
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
Phase 2
31
Brescia
2025-09-18
Recruiting
Zydus Therapeutics Inc.
Phase 2
240
Genova, Milan, Modena, Naples, Brescia
2025-09-17
Active, closed
Hoffmann-La Roche
Phase 3
1,101
Rome, Genoa, Brescia, Milan
2025-09-17
Active, closed
A Study to Test Whether Nerandomilast Helps People With Lung Fibrosis Related to Rheumatic Diseases
NCT06806592Interstitial Lung Diseases, Systemic Autoimmune Rheumatic Diseases Associated Interstitial Lung Diseases
DrugNerandomilast
Boehringer Ingelheim
Phase 3
413
Brescia, Florence, Milan, Padova, Pavia, Roma
2025-09-13
Recruiting
Janssen Research & Development, LLC
Phase 3
220
Bergamo, Brescia, Genova, Milan, Naples, Roma, Sanatorio San Luigi, Udine
2025-09-10
Recruiting
NTC srl
Phase 3
412
Carpi, Aviano, Negrar, Bologna, Brescia, Como, Milan, Roma
2025-09-02
Active, closed
Virtual Reality-Based Cognitive Remediation in Schizophrenia and Bipolar Disorder
NCT07632989Bipolar Disorder (BD), Schizophrenia Spectrum Disorders (SSD)
Università degli Studi di Brescia
Not applicable
80
Brescia
2025-09-01
Not yet open
Fondazione IRCCS San Gerardo dei Tintori
Not applicable
106
Brescia, Monza, Bergamo, Como, Genova, Milan, Padova, Parma
2025-09-01
Not yet open
Long-term Assessment of Chlormethine Gel in Mycosis Fungoides
NCT07046663Cutaneous T-Cell Lymphoma/Mycosis Fungoides
Fondazione Italiana Linfomi - ETS
Observational
190
Ancona, Bergamo, Bologna, Brescia, Cagliari, Catania, Florence, Genova
2025-09
Recruiting
Relay Therapeutics, Inc.
Phase 3
540
Ancona, Brescia, Candiolo, Cona, Florence, Livorno, Meldola, Milan
2025-08-26
Recruiting
Focused Orticumab Research for Treating Inflammation in Coronary Arteries
NCT06927739Acute Coronary Syndromes, Coronary Arterial Disease (CAD), Inflammation, Heart Disease
Abcentra
Phase 2
240
Caserta, Ferrara, Brescia, Milan, Pavia
2025-08-11
Recruiting
Mario Negri Institute for Pharmacological Research
Phase 2
21
Brescia, Florence, Genova, Milan, Padova, Parma
2025-08-07
Recruiting
AstraZeneca
Phase 3
250
Bologna, Brescia, Florence, Milan, Torino
2025-08-07
Recruiting
ACADIA Pharmaceuticals Inc.
Phase 2
180
Naples, Salerno, Brescia, Roma
2025-08-06
Recruiting
Early Ravulizumab Treatment Of Anti- AChR Antibody-Positive Generalized Myasthenia Gravis
NCT06967480Generalized Myasthenia Gravis, Anti-AChR Antibody Positive
DrugRavulizumab
Alexion Pharmaceuticals, Inc.
Observational
40
Bergamo, Bologna, Brescia, Florence, Imperia, Lecco, Messina, Milan
2025-07-31
Active, closed
Pfizer
Phase 3
208
Bologna, Brescia, Catania
2025-07-31
Recruiting
Novartis Pharmaceuticals
Observational
300
Alessandria, Asti, Bergamo, Brescia, Catania, Meldola, Cona, Foggia
2025-07-30
Active, closed
Boehringer Ingelheim
Phase 1
16
Brescia, Trieste
2025-07-29
Recruiting
Boehringer Ingelheim
Phase 3
11,800
Acquaviva Delle Fonti (BA), Bergamo, Brescia, Catania, Catanzaro, Chieti, Cona (FE), Coppito (AQ)
2025-07-22
Recruiting
Fondazione Poliambulanza Istituto Ospedaliero
Observational
180
Brescia
2025-07-21
Recruiting
Bristol-Myers Squibb
Phase 3
426
Naples, Rome, Milan, Pisa, Brescia, Isernia, Roma
2025-07-16
Recruiting
A Standard Carbon Dioxide Flushing Protocol to Reduce Air Embolization During Thoracic Endovascular Aortic Repair
NCT07734584Type B Acute Aortic Syndrome, Thoracic and Thoracoabdominal Aneurysms With Crawford Extent I, II, III, or IV
University of Bologna
Not applicable
90
Bologna, Brescia, Genova, Padova
2025-07-15
Recruiting
Takeda
Phase 3
347
Bologna, Brescia, Genoa, Messina, Milan, Pavia, Piacenza, Torino
2025-07-15
Recruiting
Bristol-Myers Squibb
Phase 3
586
Milan, Monza, Brescia
2025-07-14
Recruiting
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
NCT06991114Refractory Rheumatoid Arthritis (RA), Idiopathic Inflammatory Myopathies (IIMs), Systemic Sclerosis (SSc), Rheumatoid Arthritis (RA
Artiva Biotherapeutics, Inc.
Phase 2
90
Brescia
2025-07-09
Active, closed
REal-life ON PARKinson's - ITaly (REONPARK-IT)
NCT07403799Parkinson Disease
Bial - Portela C S.A.
Observational
200
Bari, Brescia, Cagliari, Catanzaro, Chieti, Genova, Messina, Milan
2025-07-08
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
360
Orbassano, Brescia, Milan, Naples, Roma
2025-07-03
Recruiting
Hoffmann-La Roche
Phase 3
80,000
Naples, Rome, Genoa, Brescia, Milan, Palermo, Perugia
2025-07-02
Recruiting
Alnylam Pharmaceuticals
Phase 3
1,750
Ancona, Bologna, Brescia, Florence, Forlì, Lecce, Milan, Naples
2025-07-02
Not yet open
IRCCS Centro San Giovanni di Dio Fatebenefratelli
Not applicable
120
Brescia
2025-07
Active, closed
AstraZeneca
Observational
315
Cittadella (PD), Montebelluna (TV), Aosta, Avellino, Bari, Bergamo, Brescia, Cagliari
2025-06-25
Recruiting
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
NCT07037459Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction, Obesity
DrugMaridebart cafraglutide
Amgen
Phase 3
5,056
Bari, Bergamo, Brescia, Cortona AR, Foggia, Forlì, Milan, Naples
2025-06-25
Recruiting
European Institute of Oncology
Observational
1,000
Ancona, Aviano, Bagno a Ripoli, Bari, Bergamo, Brescia, Brindisi, Busto Arsizio
2025-06-25
Recruiting
University of Padova
Observational
100
Mercogliano, Brescia, Rho, Monza, Naples, Ragusa, Cotignola, Sassari
2025-06-20
Active, closed
Incyte Corporation
Phase 3
9
Alessandria, Ancona, Bergamo, Bologna, Brescia, Catania, Florence, Genova
2025-06-04
Recruiting
AstraZeneca
Phase 3
15,100
Altamura, Arzignano, Bergamo, Bologna, Brescia, Caserta, Catania, Cona
2025-06-04
Recruiting
Janssen Research & Development, LLC
Phase 3
600
Bergamo, Bologna, Brescia, Meldola, Milan, Pavia, Perugia, Pesaro
2025-06-04
Not yet open
F.I.R.M.O. - Fondazione Italiana Ricerca sulle Malattie dell'Osso - Ente del Terzo Settore
Observational
100
Bari, Bologna, Brescia, Cagliari, Ferrara, Florence, Genova, Messina
2025-06-01
Recruiting
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
NCT06901531Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer, Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma
DrugsZolbetuximab·Adrucil·Capecitabine·Oxaliplatin
Astellas Pharma Global Development, Inc.
Phase 3
500
Bergamo, Bologna, Brescia, Candiolo, Cremona, Florence, Meldola, Milan
2025-05-22
Recruiting
Penumbra Inc.
Observational
300
Brescia, Genoa
2025-05-18
Recruiting
Hoffmann-La Roche
Phase 3
425
Matera, Bologna, Rome, Brescia, Milan, San Donato Milanese (MI), Negrar
2025-05-12
Recruiting
Biogen
Phase 3
454
Bari, Fontevivo, Modena, Piacenza, Trieste, Genoa, Brescia, Ranica
2025-05-08
Recruiting
Takeda
Phase 3
59
Milan, Rozzano, Orbassano, Brescia, Genova, Messina, Pavia, Pisa
2025-05-06
Recruiting
Exploring the Clinical Impact of MYC Aberrations and Their Relationship With Microenvironment in Diffuse Large B Cell Lymphoma and High-Grade B Cell Lymphoma
NCT06588205Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma, High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements
Fondazione Italiana Linfomi - ETS
Observational
200
Alessandria, Ancona, Bari, Brescia, Candiolo, Castelfranco Veneto, Catania, Civitanova Marche
2025-05-05
Active, closed
IRCCS Centro San Giovanni di Dio Fatebenefratelli
Not applicable
110
Brescia, Isernia, Milan, Pescara
2025-05-01
Recruiting
Lung Ultrasound for Guiding Antibiotic Use in Pediatric Pneumonia
NCT06921993Pneumonia Childhood, Pneumonia, Lung Ultrasound, Antibiotic Stewardship
Meyer Children's Hospital IRCCS
Not applicable
659
Florence, Bergamo, Bologna, Brescia, Genova, Milan, Naples, Novara
2025-04-24
Recruiting
Merck Sharp & Dohme LLC
Phase 3
770
Aviano, Milan, Pisa, Bari, Brescia, Naples, Padova, Roma
2025-04-09
Recruiting
Fondazione Italiana Linfomi - ETS
Phase 2
47
Alessandria, Pescara, Ancona, Avellino, Aviano, Brescia, Florence, Milan
2025-04-09
Active, closed
Arrowhead Pharmaceuticals
Phase 3
710
Rozzano, Bologna, Brescia, Milan, Palermo, Roma
2025-04-09
Recruiting
AstraZeneca
Phase 3
400
Bari, Bergamo, Brescia, Cagliari, Catanzaro, Genoa, Milan, Modena
2025-03-28
Recruiting
Prescient Therapeutics, Ltd.
Phase 2
115
Bologna, Brescia, Milan
2025-03-28
Recruiting
Gruppo Oncologico del Nord-Ovest
Phase 3
340
Aviano, Bari, Brescia, Crema, Cremona, Florence, Genoa, Meldola
2025-03-27
Recruiting
Mario Negri Institute for Pharmacological Research
Phase 2/3
246
Brescia, Bergamo, Milan, Naples, Novara, Padova, Palermo, Pergine Valsugana
2025-03-26
Recruiting
Immunovant Sciences GmbH
Phase 2
162
Bergamo, Bologna, Brescia, Milan, Pavia, Pisa, Roma, Siena
2025-03-18
Recruiting
AstraZeneca
Phase 3
11,300
Alessandria, Bari, Bergamo, Brescia, Chiavari, Cona, Foggia, Milan
2025-03-14
Recruiting
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
150
Pavia, Brescia, Milan, Monza
2025-03-06
Recruiting
Hoffmann-La Roche
Phase 2
130
Naples, Meldola, Brescia, Milan, Rozzano
2025-03-05
Recruiting
Capsule Gastric Endoscopy for Gastric Disease Screening in Simulated Home Scenarios
NCT06848400Gastric Lesion, Gastritis, Upper Gastrointestinal Bleeding (UGIB), Gastric Dysplasia
Nanfang Hospital, Southern Medical University
Not applicable
482
Brescia
2025-03-03
Not yet open
Consorzio Oncotech
Observational
1,000
Avellino, Bergamo, Bologna, Brescia, Termoli, Caserta, Cuneo, Ferrara
2025-03
Recruiting
Incyte Corporation
Phase 3
600
Bari, Brescia, Catania, Chieti, Florence, L’Aquila, Milan, Naples
2025-02-28
Recruiting
Systemic Therapies in the Treatment of Cutaneous T-cell Lymphoma
NCT06588868Cutaneous T Cell Lymphoma, Cutaneous T-Cell Lymphoma/Mycosis Fungoides, Cutaneous T-Cell Lymphoma/Sezary Syndrome
Fondazione Italiana Linfomi - ETS
Observational
400
Ancona, Bari, Bologna, Brescia, Cagliari, Catania, Florence, Genova
2025-02-27
Recruiting
Istituto Clinico Humanitas
Observational
300
Benevento, Bergamo, Brindisi, Brescia, Campobasso, Florence, Genova, Messina
2025-02-25
Active, closed
Post Market Registry for GORE® TAG® Thoracic Branch Endoprosthesis
NCT06507865Aneurysm, Dissection, Aortic, TAA Thoracoabdominal Aortic Aneurysm, Thoracic Aortic Aneurysm
W.L.Gore & Associates
Observational
155
Bologna, Brescia, Cagliari, Genova, Padova
2025-02-20
Recruiting
Novo Nordisk A/S
Phase 3
510
Orbassano, Verona, Brescia, Catania, Modena, Monza, Naples, Padova
2025-02-17
Recruiting
Study on Plasmablastic Lymphoma Patients
NCT06781359Plasmablastic Lymphoma
Fondazione Italiana Linfomi - ETS
Observational
200
Aviano, Ascoli Piceno, Brescia, Cuneo, Florence, Milan, Monza, Novara
2025-02-14
Recruiting
Università degli Studi di Brescia
Not applicable
120
Brescia
2025-02-13
Active, closed
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Observational
2,000
Acquaviva delle Fonti, Ancona, Avellino, Bari, Bolzano, Brescia, Casale Monferrato, Caserta
2025-02-12
Recruiting
Dr. Inge Winter
Phase 3
418
Brescia, Cagliari, Naples, Turin
2025-02-11
Recruiting
AbbVie
Observational
1,200
Rozzano, Milan, Naples, Rome, Ancona, Brescia, Campobasso, Catania
2025-01-31
Active, closed
Novartis Pharmaceuticals
Phase 3
588
Ancona, Brescia, Catania, Cona, Florence, Rozzano, Modena, Pisa
2025-01-31
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,046
Monza, Rionero in Vulture, Palermo, Candiolo, Ancona, Brescia, Milan, Novara
2025-01-27
Recruiting
Incyte Corporation
Phase 3
240
Alessandria, Ancona, Bari, Brescia, Catania, Genova, Milan, Naples
2025-01-21
Active, closed
argenx
Phase 3
631
Brescia, Pisa, Roma
2025-01-15
Recruiting
Janssen Research & Development, LLC
Phase 3
750
Ancona, Brescia, Catania, Milan, Naples, Pavia, Roma, Rozzano
2025-01-09
Recruiting
A Multicenter Study on Atrioventricular Regurgitation in Transthyretin Amyloid Cardiomyopathy: Definition, Prevalence, and Prognostic Impact.
NCT06836011ATTR Amyloidosis With Cardiomyopathy, ATTR-CM, ATTR Amyloidosis Wild Type, Mitral Regurgitation
Medical University of Vienna
Observational
600
Brescia, Ferrara, Trieste
2025-01-01
Active, closed
mAbxience Research S.L.
Phase 3
726
Brescia, Cremona, Genova, Lecce, Meldola, Pavia, Roma, Siena
2024-12-30
Recruiting
Fundación para la Investigación Biosanitaria del Principado de Asturias
Not applicable
250
Brescia, Genova, Milan, San Donato Milanese
2024-12-24
Recruiting
Size Up Bicuspid With the LIra MEthod: the SUBLIME Study
NCT06657911Bicuspid Aortic Valve (BAV)
IRCCS San Raffaele
Observational
250
Brescia, Milan, Roma
2024-12-21
Recruiting
Cytokinetics
Phase 3
1,800
Brescia, Rimini, Arzignano, Bergamo, Milan, Sesto San Giovanni, Perugia, Cona
2024-12-19
Recruiting
Sanofi
Phase 2
84
Florence, Naples, Brescia, Monza
2024-12-19
Active, closed
Phase 2 Study of Rapcabtagene Autoleucel in Myositis
NCT06665256Idiopathic Inflammatory Myopathies
DrugRapcabtagene autoleucel
Novartis Pharmaceuticals
Phase 2
21
Ancona, Brescia, Monza, Milan, Rozzano, Verona
2024-12-17
Recruiting
The Leeds Teaching Hospitals NHS Trust
Observational
550
Brescia, Catania, Genova, Milan, Palermo, San Donato Milanese, Torino, Verona
2024-12-12
Active, closed
Hoffmann-La Roche
Phase 3
350
Rome, Brescia, Milan, Monza MI, Rozzano (MI), Negrar
2024-12-11
Recruiting
IRCCS Centro San Giovanni di Dio Fatebenefratelli
Not applicable
60
Brescia, Messina, Milan
2024-12-09
Recruiting
Novo Nordisk A/S
Phase 2
465
L’Aquila, Chieti, Bologna, Bergamo, Brescia, Milan, Pisa, Roma
2024-12-02
Recruiting
Washington University School of Medicine
Phase 2/3
280
Brescia, Florence
2024-11-22
Recruiting
Washington University School of Medicine
Phase 2/3
280
Brescia, Florence
2024-11-22
Recruiting
UCB Biopharma SRL
Phase 3
450
Brescia, Genova, Milan, Padova, Pisa, Roma, Rozzano
2024-11-21
Active, closed
Daiichi Sankyo
Phase 3
700
Bari, Brescia, Meldola, Milan, Novara, Palermo, Roma, Rome
2024-11-19
Active, closed
Pfizer
Phase 3
200
L’Aquila, Bari, Milan, Rome, Brescia, Latina, Pavia, Roma
2024-11-15
Recruiting
Gruppo Oncologico del Nord-Ovest
Phase 3
238
Brescia, Catania, Meldola, San Giovanni Rotondo, Florence, Tricase, Livorno, Lucca
2024-11-15
Active, closed
BeOne Medicines
Phase 2
94
Brescia, Florence, Modena, Palermo
2024-11-14
Recruiting
Functional Capacity in Anderson-Fabry Disease Patients
NCT06884358Anderson-Fabry Disease
IRCCS Policlinico S. Donato
Observational
100
Brescia, Milan, San Donato Milanese, Monza, Turin
2024-11-13
Recruiting
F.I.R.M.O. - Fondazione Italiana Ricerca sulle Malattie dell'Osso - Ente del Terzo Settore
Observational
600
Alessandria, Bari, Bologna, Brescia, Cagliari, Ferrara, Florence, Foggia
2024-11-04
Recruiting
Hospital Universitario 12 de Octubre
Not applicable
440
Pozzilli, Acerra, Brescia, Latina, Maddaloni, Monza, Naples, Padova
2024-11-01
Recruiting
Gruppo Italiano Malattie EMatologiche dell'Adulto
Observational
100
Ancona, Bergamo, Bologna, Brescia, Candiolo, Florence, Milan, Naples
2024-11-01
Active, closed
Fondazione Italiana Linfomi - ETS
Observational
241
Milan, Aviano, Bergamo, Bologna, Brescia, Cagliari, Cuneo, Florence
2024-10-30
Active, closed
Novartis Pharmaceuticals
Phase 2
96
Ancona, Bergamo, Brescia, Genova, Milan, Pescara, Perugia, Pisa
2024-10-29
Active, closed
Fondazione Italiana Linfomi - ETS
Phase 2
56
Candiolo, Alessandria, Ancona, Bologna, Brescia, Catania, Florence, Milan
2024-10-23
Recruiting
The Sagittarius Trial
NCT06490536Colon Cancer Stage II, Colon Cancer Stage III
DrugsFolinic acid·Panitumumab·Pertuzumab·Temozolomide
IFOM ETS - The AIRC Institute of Molecular Oncology
Phase 3
700
Biella, Brescia, Genova, Milan, Rozzano, Novara, Parma, Perugia
2024-10-22
Recruiting
North Eastern German Society of Gynaecological Oncology
Phase 2
640
Bologna, Brescia, Lecco, Milan, Monserrato, Padova, Pisa, Reggio Emilia
2024-10-11
Active, closed
Eli Lilly and Company
Phase 2
143
Bologna, Brescia, Fano, Florence, Gazzi - Messina, Milan, Modena, Monserrato
2024-10-10
Recruiting
Rhu-pGSN for Acute Respiratory Distress Syndrome (ARDS)
NCT05947955Acute Respiratory Distress Syndrome, Infections
BioAegis Therapeutics Inc.
Phase 2
600
Brescia, Rome
2024-10-03
Recruiting
Primary Cardiac Lymphoma: Italian Multicenter Experience
NCT05819528Primary Cardiac Lymphoma
Fondazione Italiana Linfomi - ETS
Observational
43
Bergamo, Brescia, Ferrara, Milan, Perugia, Pisa, Roma, Sassari
2024-10-02
Recruiting
Effectiveness of EMDR in Borderline Personality Disorder
NCT06493708Borderline Personality Disorder
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
Not applicable
56
Brescia
2024-10-01
Recruiting
Diagnosis and Treatment of Late Neurological Ischemic Deficit in Patients Suffering From Subarachnoid Hemorrhage.
NCT06804421Aneurysmal Subarachnoid Haemorrhage, Delayed Ischemic Neurological Deficit
Fondazione IRCCS San Gerardo dei Tintori
Observational
1,400
Bergamo, Bologna, Brescia, San Fermo della Battaglia, Cremona, Florence, Genova, Lecco
2024-09-28
Recruiting
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Phase 3
406
Salerno, Rome, Brescia, Milan, Ponderano (Biella), Roma
2024-09-26
Active, closed
Merus B.V.
Phase 3
699
Ancona, Brescia, Cagliari, Meldola, Milan, Naples, Rome, Rozzano
2024-09-25
Active, closed
A Study to Evaluate the Efficacy and Safety of Sotagliflozin in Symptomatic Obstructive and Non-obstructive Hypertrophic Cardiomyopathy
NCT06481891Obstructive Cardiomyopathy, Hypertrophic, Non-obstructive Hypertrophic Cardiomyopathy
DrugSotagliflozin
Lexicon Pharmaceuticals
Phase 3
500
Arezzo, Brescia, Naples
2024-09-24
Recruiting
Heart Care Foundation
Observational
5,000
Montevarchi, Acquaviva delle Fonti, Altamura, Bari, Brescia, Monserrato, Catania, Campobasso
2024-09-15
Recruiting
SPAGO: Sirolimus Paclitaxel Angiographic Gain Objective
NCT06373601Coronary Artery Disease, Stenosis Coronary, Coronary Artery Lesion, Percutaneous Coronary Intervention
Fondazione Evidence per Attività e Ricerche Cardiovascolari ONLUS
Not applicable
140
Mercogliano, Bergamo, Brescia, Ferrara, Milan, Rozzano, Naples, Orbassano
2024-09-05
Recruiting
Dr. Inge Winter
Phase 3
418
Brescia, Cagliari, Naples, Turin
2024-08-31
Recruiting
Colorado Prevention Center
Phase 3
2,600
Brescia, Germaneto
2024-08-20
Recruiting
Intra-Cellular Therapies, Inc.
Phase 2
370
Brescia, Cefalù
2024-08-15
Recruiting
Dr. Inge Winter
Phase 4
418
Brescia, Cagliari, Naples, Turin
2024-08-01
Recruiting
Janssen Research & Development, LLC
Phase 3
752
Brescia, Catania, Chieti, Genova, Monza, Pisa, Roma, Salerno
2024-07-25
Active, closed
Merck Sharp & Dohme LLC
Phase 3
686
Bologna, Milan, Monza, Rozzano, Turin, Brescia, Catania, Naples
2024-07-24
Active, closed
Arrowhead Pharmaceuticals
Phase 3
446
Rozzano, Palermo, Bologna, Brescia, Milan, Roma
2024-07-22
Recruiting
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)
Phase 2
385
Bologna, Brescia, Catanzaro, Milan, Negrar, Padova, Roma, Rozzano
2024-07-18
Recruiting
Amgen
Phase 3
450
Brescia, Castellana Grotte, Florence, Foggia, Genova, Meldola FC, Milan, Naples
2024-07-17
Active, closed
AstraZeneca
Phase 3
339
Brescia, Cona, Florence, Milan, Naples, Reggio Emilia, Roma, Rome
2024-06-29
Recruiting
Master Framework For Relapse or Refractory Acute Myeloid Leukemia
NCT06459024Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Observational
4,000
Bologna, Brindisi, Brescia, Cuneo, Como, Cremona, Ferrara, Genova
2024-06-28
Recruiting
A Study to Describe the Diagnostic and Therapeutic Path of Patients with NSCLC in Early Stage and Locally Advanced
NCT06467383Non-small Cell Lung Cancer, NSCLC, NSCLC, Stage III, NSCLC, Stage I
MSD Italia S.r.l.
Observational
600
San Giovanni Rotondo, Brescia, Campobasso, Catania, Florence, Genova, Messina, Milan
2024-06-25
Active, closed
Merus B.V.
Phase 3
621
Brescia, Cuneo, Milan, Naples, Roma, Rozzano
2024-06-25
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,530
Naples, Misterbianco, Meldola (FC), Aviano, Rome, Brescia, Milan, Monza
2024-06-24
Recruiting
How Complexity and Multiple Illnesses Affect Hospitalized Patients' Health: a Multicenter Study
NCT06872632Complexity and Multiple Illnesses of Adult Hospitalized Internal Medicine Patient
Società Italiana di Medicina Interna
Observational
2,326
Bari, Bologna, Brescia, Ferrara, Florence, Messina, Milan, Modena
2024-06-24
Recruiting
Merck Sharp & Dohme LLC
Phase 3
851
Naples, Rome, Milan, Monza, Rozzano, Brescia, Genova, Novara
2024-06-10
Recruiting
LEO Pharma
Phase 3
195
Ancona, Brescia, Padova, Roma, Rome
2024-06-10
Active, closed
Exelixis
Phase 2/3
600
Candiolo, Brescia, Catania, Milan, Naples, Rome, Rozzano, Verona
2024-06-07
Active, closed
Janssen Research & Development, LLC
Phase 1
108
Ancona, Bergamo, Brescia, Meldola, Pisa, Rome
2024-06-07
Active, closed
GlaxoSmithKline
Phase 4
303
Brescia, Ferrara, Milan, Pisa, Reggio Emilia, Rome, Rozzano
2024-06-06
Recruiting
X4 Pharmaceuticals
Phase 3
176
Torrette, Brescia, Genova, Meldola, Monza, Roma, Torino
2024-06-06
Recruiting
Kartos Therapeutics, Inc.
Phase 3
600
Alessandria, Ancona, Bologna, Brescia, Catania, Florence, Forlì, Milan
2024-06-03
Active, closed
Windtree Therapeutics
Phase 1/2
20
Alessandria, Brescia, Milan, Turin
2024-06-01
Recruiting
University Hospital, Antwerp
Phase 3
174
Milan, Arezzo, Bergamo, Brescia, Florence, Lecco, Pavia, Pisa
2024-05-24
Recruiting
Fondazione Italiana Linfomi - ETS
Phase 2
28
Alessandria, Aviano, Bologna, Brescia, Milan, Naples, Novara, Palermo
2024-05-23
Recruiting
Daiichi Sankyo
Phase 3
540
Bari, Bergamo, Brescia, Catania, Catanzaro, Genova, Milan, Monza
2024-05-21
Active, closed
International Extranodal Lymphoma Study Group (IELSG)
Phase 3
122
Bari, Bologna, Brescia, Catania, Meldola, Milan, Novara, Palermo
2024-05-21
Active, closed
Boehringer Ingelheim
Phase 3
1,666
Brescia, Catania, Florence, Foggia, Forlì, Milan, Modena, Monza
2024-05-06
Recruiting
Enhanced Valves Interventions and Safe AI Generated End Results
NCT07213531Heart Valve Disease, TAVI, M-TEER, TTVI
Montreal Heart Institute
Observational
21,000
Brescia, Milan
2024-05-01
Recruiting
CSL Behring
Phase 2/3
3,110
Bologna, Brescia, Cagliari, Caserta, Catania, Ferrara, Florence, Foggia
2024-04-27
By invitation
ACADIA Pharmaceuticals Inc.
Phase 3
752
Brescia, Salerno, Tricase
2024-04-23
Recruiting
Janssen Research & Development, LLC
Phase 3
641
Arezzo, Bergamo, Brescia, Milan, Roma, Rozzano, Torino
2024-04-18
Recruiting
Fondazione Italiana Linfomi - ETS
Observational
130
Alessandria, Ancona, Avellino, Aviano, Brescia, Castelfranco Veneto, Florence, Milan
2024-04-18
Recruiting
AstraZeneca
Phase 3
3,850
Acquaviva delle Fonti, Bari, Bergamo, Brescia, Catania, Catanzaro, Cona, Cortona
2024-04-12
Recruiting
International Extranodal Lymphoma Study Group (IELSG)
Observational
300
Alessandria, Bari, Bergamo, Brescia, Catania, Cona, Florence, Messina
2024-04-11
Recruiting
IRCCS Centro San Giovanni di Dio Fatebenefratelli
Observational
75
Brescia
2024-04-09
Active, closed
Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)
NCT06291376Immunoglobulin A Nephropathy, IgAN
DrugRavulizumab
Alexion Pharmaceuticals, Inc.
Phase 3
584
Agrigento, Bologna, Brescia, Cagliari, Florence, Milan, Padova, Parma
2024-03-29
Active, closed
Gilead Sciences
Phase 3
577
Brescia, Foggia, Milan, Monza, Pavia, Roma
2024-03-25
Recruiting
Verastem, Inc.
Phase 3
270
Aviano, Brescia, Catania, Milan, Naples, Padova, Roma, Rome
2024-03-18
Recruiting
Novartis Pharmaceuticals
Phase 3
450
Brescia, Cona, Genova, Milan, Rozzano, Pisa, Roma, Negrar
2024-03-12
Recruiting
Novartis Pharmaceuticals
Phase 2
502
Ancona, Bergamo, Bologna, Brescia, Caserta, Cona, Pozzilli, Milan
2024-03-07
Active, closed
Byondis B.V.
Phase 1
17
Brescia, Candiolo, Milan, Ravenna
2024-03-04
Recruiting
Lifestyles Implemented-Survivorship Care Plan In Lymphoma Survivors
NCT05934084Classical Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma (DLBCL), Primary Mediastinal Large B-cell Lymphoma (PMBCL)
Fondazione Italiana Linfomi - ETS
Not applicable
552
Ancona, Aviano, Bari, Belluno, Barletta, Bolzano, Brescia, Brindisi
2024-02-26
Recruiting
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Phase 4
84
Brescia, Lecco, Padova, Aviano, Torino, Milan
2024-02-26
Recruiting
Pulmonx Corporation
Not applicable
200
Brescia
2024-02-22
Active, closed
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
762
Meldola (Fc), Milan, Monza, Genova, Brescia, Roma, Ancona, Aviano (PN)
2024-02-21
Recruiting
Comparison of Allegra vs Sapien Transcatheter Aortic Valves in Valve-In-Valve Indication
NCT06049654Aortic Valve Stenosis, Structural Valve Deterioration
Fundación EPIC
Not applicable
104
Alessandria, Brescia, Perugia
2024-02-01
Recruiting
The DANCEREX Proof-of-Concept Study for Chronic Neurological Disorders
NCT06112639Sclerosis, Multiple, Neurocognitive Impairment, Mild, Neurocognitive Dysfunction
Fondazione Don Carlo Gnocchi ETS
Not applicable
192
Brescia, Messina, Milan
2024-01-31
Recruiting
Genexine, Inc.
Phase 3
429
Brescia, Florence, Foggia, Genova, Pavia, Pisa, Verona
2024-01-25
Active, closed
DualityBio Inc.
Phase 3
541
Bergamo, Brescia, Catania, Catanzaro, Milan, Pavia, Verona, Naples
2024-01-18
Recruiting
Colorado Prevention Center
Phase 3
5,200
Bergamo, Catanzaro, Genova, Varese, Ancona, Brescia
2024-01-17
Recruiting
Ryvu Therapeutics SA
Phase 2
98
Meldola, Ancona, Bologna, Brescia, Lecce, Ravenna, Roma, Rozzano
2024-01-05
Recruiting
Bristol-Myers Squibb
Phase 1/2
460
Bologna, Brescia, Milan, Pisa, Ravenna, Roma, Verona
2023-12-29
Recruiting
Regeneron Pharmaceuticals
Phase 3
580
Meldola, Genoa, Monza, Turin, Aviano, Candiolo, Bologna, Brescia
2023-12-28
Recruiting
Ascentage Pharma Group Inc.
Phase 3
400
Aviano, Brescia, Cona, Genova, Lecce, Meldola, Milan, Padova
2023-12-20
Recruiting
Observational Study Protocol: LIVER-R
NCT06252753Hepatobiliary Cancers
AstraZeneca
Observational
4,000
Naples, Rome, Brescia, Milan, Rozzano, Turin, Monserrato, Pisa
2023-12-20
Active, closed
AbbVie
Phase 3
614
Rome, Brescia
2023-12-19
Recruiting
Fondazione Italiana Linfomi - ETS
Phase 3
190
Sassuolo, Alessandria, Avellino, Aviano, Bari, Biella, Brescia, Cagliari
2023-12-14
Recruiting
Regeneron Pharmaceuticals
Phase 3
822
Meldola, Tricase, Genoa, Candiolo, Ascoli Piceno, Bologna, Brescia, Milan
2023-12-12
Active, closed
Merck Sharp & Dohme LLC
Phase 3
710
Bologna, Aviano, Rome, Milan, Rozzano, Candiolo, Bari, Brescia
2023-12-06
Recruiting
The Viability Control of Human Endothelial Cells Before Keratoplasty (V-CHECK) Study
NCT05847387Corneal Transplant Failure, Corneal Endothelial Cell Loss
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
Observational
135
Brescia, Bologna, Catanzaro, Roma, Venice, Vicenza
2023-12-01
Recruiting
The Fourth Left Atrial Appendage Occlusion Study
NCT05963698Atrial Fibrillation, Stroke, Ischemic, Systemic Embolism
Hamilton Health Sciences Corporation
Not applicable
4,000
Brescia, Sassari
2023-11-30
Recruiting
Sanofi
Observational
230
Bologna, Brescia, Florence, Milan, Naples, Roma, Verona
2023-11-30
Active, closed
Incyte Corporation
Phase 3
450
Brescia, Catania, Milan, Rome, Rozzano
2023-11-27
Active, closed
Gyrate Atrophy Ocular and Systemic Study
NCT05312736Gyrate Atrophy, Gyrata of Choroid and Retina; Atrophy, Ornithine-δ-aminotransferase, OAT
Jaeb Center for Health Research
Observational
46
Brescia
2023-11-21
Recruiting
Amgen
Phase 3
750
Bari, Brescia, Candiolo, Catania, Florence, Meldola (FC), Milan, Monza (MB)
2023-11-16
Recruiting
ACP-204 in Adults With Alzheimer's Disease Psychosis
NCT06159673Alzheimer's Disease Psychosis
DrugACP-204
ACADIA Pharmaceuticals Inc.
Phase 2/3
1,074
Brescia, Cefalù, Isernia, Milan, Roma, Salerno, Torino, Tricase
2023-11-14
Active, closed
AstraZeneca
Phase 3
314
Ancona, Brescia, Cona, Milan, Padova, Roma
2023-11-08
Recruiting
Gruppo Oncologico del Nord-Ovest
Phase 2/3
300
Ancona, Bergamo, Bologna, Brescia, Cuneo, Meldola, Milan, Modena
2023-11-07
Recruiting
Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1)
NCT05862012Relapsed/Refractory Multiple Myeloma
Ichnos Sciences SA
Phase 1
200
Brescia, Milan
2023-11-01
Active, closed
A Study to Investigate Efficacy and Safety of BCL2 Inhibitor Sonrotoclax as Monotherapy and in Combination With Zanubrutinib in Adults With Waldenström Macroglobulinemia
NCT05952037Waldenstrom Macroglobulinemia, Waldenstrom's Macroglobulinemia Recurrent, Waldenstrom's Macroglobulinemia Refractory
DrugsSonrotoclax·Zanubrutinib
BeOne Medicines
Phase 2
114
Bologna, Brescia, Milan, Pavia, Roma, Udine
2023-10-23
Active, closed
LEO Pharma
Phase 4
42
Brescia
2023-10-22
Recruiting
AbbVie
Phase 3
1,500
Florence, L’Aquila, Rozzano, Naples, Rome, Bologna, Brescia, Catania
2023-10-11
Active, closed
Merck Sharp & Dohme LLC
Phase 3
14,550
Cona, Rome, Bergamo, Brescia, Milan, Monza, Turin, Palermo
2023-10-09
Active, closed
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Observational
180
Sesto Fiorentino, Brescia, Milan
2023-10-03
Recruiting
Novartis Pharmaceuticals
Phase 3
106
Bari, Ranica, Brescia, Milan, Roma, Torino, Naples
2023-10-02
Recruiting
Abbott Medical Devices
Observational
1,000
Brescia, Castel Volturno, Milan, Palermo, Roma, San Donato Milanese, Torino
2023-09-29
Recruiting
Fondazione Italiana Linfomi - ETS
Observational
654
Alessandria, Biella, Brescia, Catania, Cuneo, Florence, Genova, Meldola
2023-09-19
Active, closed
Mario Negri Institute for Pharmacological Research
Phase 4
190
San Fermo della Battaglia, Brescia, Florence, Lecco, Lucca, Milan, Padova, Parma
2023-09-15
Active, closed
Bristol-Myers Squibb
Phase 3
774
Brescia, Milan, Naples, Pisa, Rome, Udine
2023-09-11
Recruiting
The ReTAVI Prospective Observational Registry
NCT05601453Structural Valve Deterioration, Structural Valve Degeneration, Symptomatic Patients Who Have Had Transcatheter Heart Valve (THV) Failure, Prosthetic Valve Malfunction
Institut für Pharmakologie und Präventive Medizin
Observational
250
Ancona, Bologna, Brescia, Florence, Milan, Padua, Pisa, Roma
2023-09-05
Active, closed
Cytokinetics
Phase 3
500
San Donato Milanese, Brescia, Florence, Foggia, Milan, Naples, Pisa, Roma
2023-08-31
Recruiting
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Phase 3
1,000
Salerno, Rome, Brescia, Milan, Baggiovara, Ponderano (Biella), Florence, Monza
2023-07-11
Recruiting
Fondazione Poliambulanza Istituto Ospedaliero
Observational
400
Brescia
2023-07-01
Active, closed
AbbVie
Phase 3
1,328
Cona, Florence, L’Aquila, Rome, Brescia, Milan, Modena, Pisa
2023-06-21
Recruiting
Servier Affaires Médicales
Phase 3
245
Meldola, Brescia, Genova, Perugia
2023-06-14
Recruiting
Innate srl
Not applicable
55
Brescia, Rozzano, Roma
2023-06-01
Recruiting
Jaeb Center for Health Research
Observational
1,500
Brescia
2023-05-11
Recruiting
Novartis Pharmaceuticals
Phase 3
200
Brescia, Catania, Florence, Pavia, Roma, Naples
2023-05-11
Active, closed
Novartis Pharmaceuticals
Phase 1
71
Brescia, Rozzano
2023-05-08
Recruiting
Exploring the Gut-Brain Axis in Ageing and Neurodegeneration
NCT05934188Healthy, Prodromal Alzheimer's Disease, Parkinson Disease, Multiple Sclerosis
IRCCS San Camillo, Venezia, Italy
Observational
200
Venice-Lido, Brescia, Venice
2023-05-01
Recruiting
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Observational
3,500
Aviano, Brescia, Catania, Como, Cremona, Florence, Genova, Meldola
2023-05-01
Recruiting
Consorzio Oncotech
Phase 2
118
Brescia, Candiolo, Catania, Cremona, Florence, Genova, Milan, Modena
2023-04-18
Active, closed
Karyopharm Therapeutics Inc
Phase 3
257
Bologna, Brescia, Meldola, Milan, Monza, Naples, Padova, Pisa
2023-04-18
Recruiting
Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women
NCT04124120Heart Diseases, Coronary Artery Disease, Coronary Artery Bypass Grafting
Weill Medical College of Cornell University
Not applicable
2,300
Bari, Bergamo, Brescia, Cotignola, Florence, Roma, Torino
2023-04-17
Recruiting
Eli Lilly and Company
Phase 1/2
880
Alessandria, Brescia, Milan, Monza, Pisa, Ravenna, Roma, Verona
2023-04-17
Recruiting
ReGenTree, LLC
Phase 3
70
Brescia, Florence
2023-04-11
Active, closed
Sanofi
Phase 2
999
Milan, Naples, Rome, Brescia, Vicenza
2023-04-03
Active, closed
Bial R&D Investments, S.A.
Phase 2
237
Bologna, Brescia, Brindisi, Milan, Naples, Padova, Roma, Rozzano
2023-03-31
Active, closed
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
NCT05739383Primary Prevention of Atherosclerotic Cardiovascular Disease
DrugInclisiran
Novartis Pharmaceuticals
Phase 3
14,012
Ancona, Brescia, Caserta, Chieti, Catanzaro, Florence, Chiavari, Genova
2023-03-09
Recruiting
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2
43
Brescia, Torino
2023-03-07
Active, closed
AstraZeneca
Phase 2
188
Avellino, Brescia, Lecce, Milan, Naples, Palermo, Peschiera del Garda, Reggio Emilia
2023-03-06
Recruiting
Post-market European & Asian Registry to Evaluate the Minos™ Stent-Graft and Delivery System in Abdominal Aortic Aneurysm Treatment
NCT07674173Endovascular Repair of Infrarenal Abdominal Aortic Aneurysm Using Endovascular Stent Graft
Shanghai MicroPort Endovascular MedTech（Group）Co., Ltd
Observational
200
Brescia
2023-03-05
Active, closed
Novartis Pharmaceuticals
Phase 2
33
Brescia, Florence, Genova, Milan, Roma
2023-02-28
Active, closed
Fondazione Italiana Linfomi - ETS
Phase 1/2
122
Alessandria, Candiolo, Avellino, Aviano, Bari, Brescia, Lecce, Meldola
2023-02-27
Active, closed
AstraZeneca
Observational
551
Naples, Cona, Udine, Rome, Brescia, Milan, Turin, Cagliari
2023-02-27
Active, closed
Janssen Research & Development, LLC
Phase 3
12,523
Brescia, Cremona, Foligno, Genova, Gubbio, Lecce, Lecco, L’Aquila
2023-02-15
Active, closed
Kite, A Gilead Company
Phase 3
300
Bologna, Brescia, Milan, Perugia, Reggio Calabria, Rome, Rozzano
2023-02-10
Active, closed
Fondazione Italiana Linfomi - ETS
Observational
160
Milan, Siena, Aviano, Brescia, Cuneo, Florence, Novara, Padova
2023-02-08
Active, closed
Genmab
Phase 3
900
Alessandria, Bari, Brescia, Bologna, San Giovanni Rotondo, Milan, Naples, Palermo
2023-02-08
Recruiting
Medtronic Cardiovascular
Not applicable
400
Bologna, Brescia, Milan, Pisa, San Donato Milanese
2023-02-07
Recruiting
Istituto Clinico Humanitas
Not applicable
146
Brescia, Florence, Rozzano, Milan, Naples, Rome, Terni
2023-01-31
Active, closed
Stemline Therapeutics, Inc.
Phase 1/2
435
Brescia, Milan, Naples, Rimini
2023-01-24
Active, closed
ABTECT - Maintenance
NCT05535946Ulcerative Colitis
DrugObefazimod
Abivax S.A.
Phase 3
1,116
San Giovanni Rotondo, Rho, Rozzano, San Donato Milanese, Negrar, Alessandria, Bologna, Brescia
2023-01-16
Active, closed
Bristol-Myers Squibb
Phase 3
516
Rome, Milan, Pisa, Padova, Brescia, Naples, Verona
2023-01-12
Active, closed
Zenas BioPharma (USA), LLC
Phase 3
194
Turin, Brescia, Florence, Milan, Verona
2023-01-09
Active, closed
Exelixis
Phase 3
317
Rozzano, Candiolo, Arezzo, Bari, Brescia, Meldola, Milan, Naples
2023-01-01
Recruiting
Risk of Recurrent CeAD After Pregnancy
NCT06258109Cervical Artery Dissection, Pregnancy Complications
University Hospital, Basel, Switzerland
Observational
1,000
Brescia
2023-01-01
Recruiting
Anthos Therapeutics, Inc.
Phase 3
2,500
Ancona, Bologna, Brescia, Cagliari, Caserta, Catanzaro, Cinisello Balsamo, Florence
2022-12-27
Active, closed
AriBio Co., Ltd.
Phase 3
1,535
Ancona, Brescia, Milan, Monza, Pisa, Roma, Torino, Tricase
2022-12-23
Recruiting
European Myeloma Network (EMN) Sample Project
NCT06237803Multiple Myeloma, Smoldering Multiple Myeloma, Plasma Cell Leukemia, Extramedullary Myeloma
European Myeloma Network B.V.
Observational
6,000
Alessandria, Ancona, Bari, Bologna, Brescia, Civitanova Marche, Florence, Genova
2022-12-21
Recruiting
Canadian Cancer Trials Group
Phase 2
393
Florence, Brescia, Lecco, Milan, Rome
2022-12-19
Active, closed
Amgen
Phase 3
7,297
Arzignano, Bologna, Brescia, Caserta, Catania, Catanzaro, Cona FE, Florence
2022-12-14
Recruiting
Iperboreal Pharma Srl
Phase 3
170
Ascoli Piceno, Bagno a Ripoli, Bari, Brescia, Chieti, Genova, L’Aquila, Milan
2022-12-14
Recruiting
AstraZeneca
Phase 3
3,527
Arezzo, Brescia, Naples, Roma, Rozzano, Torino
2022-12-13
Recruiting
Quality Of Life On Elderly Patients With Low Grade Non-Hodgkin Lymphoma
NCT05524298Low Grade Non-Hodgkin's Lymphoma, Adult
Fondazione Italiana Linfomi - ETS
Observational
150
Alessandria, Ancona, Bari, Brescia, Castelfranco Veneto, Catania, Florence, Messina
2022-12-07
Recruiting
Neurosurgical Outcome Network
NCT06724029Aneurysms, Arteriovenous Malformations, Cavernomas, Skull Base Tumors
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Observational
4,500
Bergamo, Brescia, Gravedona, Como, Cremona, Monza, Pavia, Sondrio
2022-12-05
Active, closed
AstraZeneca
Phase 3
1,174
Bologna, Brescia, Florence, Genova, Livorno, Meldola, Messina, Milan
2022-11-28
Active, closed
Alexion Pharmaceuticals, Inc.
Phase 3
260
Bergamo, Brescia, Florence, Milan, Naples, Palermo, Pisa, Roma
2022-11-21
Active, closed
Safety and Efficacy of FT14 Conditioning for Allogeneic HSCT in Acute Myeloid Leukemia
NCT07232953Acute Myeloid Leukaemia (AML), Hematopoietic Stem Cell Transplant (HSCT)
DrugsTreosulfan·Fludarabine
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
Phase 2
82
Reggio Calabria, Naples, Modena, Udine, Brescia, Milan, Cuneo, Ancona
2022-11-10
Recruiting
Endospan Ltd.
Observational
70
Brescia, Padova
2022-11-09
Recruiting
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
400
Monserrato, Avellino, Rome, Tricase, Brescia, Milan, Naples, Verona
2022-10-24
Active, closed
Almirall, S.A.
Phase 4
447
Arezzo, Brescia, Genova, Modena, Naples, Reggio Emilia, Roma, Rozzano
2022-10-24
Recruiting
National Database on Primary Sclerosing Cholangitis (PSC)
NCT05618145Primary Sclerosing Cholangitis
University of Milano Bicocca
Observational
6,000
Ancona, Bari, Bergamo, Bologna, Bolzano, Brescia, Cagliari, Castellana Grotte
2022-10-21
Active, closed
Janssen Research & Development, LLC
Phase 3
864
Ancona, Bari, Bologna, Brescia, Catania, Milan, Padova, Palermo
2022-10-13
Active, closed
Ponatinib Plus Chemotherapy in Acute Lymphoblastic Leukemia Patients
NCT05306301Chemotherapy, Leukemia, Acute Lymphoblastic
DrugPonatinib
Gruppo Italiano Malattie EMatologiche dell'Adulto
Phase 2
32
Avellino, Pagani, Bergamo, Bologna, Brescia, Catania, Florence, Lecce
2022-10-05
Recruiting
Letrozole for Estrogen/Progesterone Receptor Positive Low-grade Serous Epithelial Ovarian Cancer (LEPRE Trial)
NCT05601700Carcinoma, Ovarian Epithelial, Low Grade Serous Adenocarcinoma of Ovary
DrugLetrozole
Ente Ospedaliero Ospedali Galliera
Phase 3
132
Arezzo, Ponderano, Belluno, Brescia, Como, Meldola, Ferrara, Genova
2022-09-22
Active, closed
Biogen
Phase 2/3
450
Bologna, Brescia, Florence, Genova, Milan, Naples, Roma
2022-09-13
Recruiting
European Myeloma Network B.V.
Phase 3
1,594
Alessandria, Ancona, Bari, Bergamo, Bologna, Brescia, Cagliari, Cosenza
2022-09-08
Recruiting
University of Milano Bicocca
Observational
500
Bari, Bologna, Brescia, Catania, Naples, Roma, Torino, Udine
2022-09-08
Active, closed
Biogen
Phase 2
416
Tricase, Cefalù, Arzignano VI, Brescia, Milan, Perugia, Roma
2022-08-24
Active, closed
Gilead Sciences
Phase 3
443
Bari, Bologna, Brescia, Genova GE, Lecco, Lucca, Milan, Monza
2022-07-25
Active, closed
Gilead Sciences
Phase 3
623
Bari, Bologna, Brescia, Genova GE, Lecco, Lucca, Milan, Monza
2022-07-20
Active, closed
Hoffmann-La Roche
Phase 3
922
Naples, Reggio Emilia, Rimini, Rome, Brescia, Milan, Rozzano, Misterbianco (CT)
2022-07-18
Active, closed
Regeneron Pharmaceuticals
Phase 3
1,546
Naples, San Giovanni Rotondo, Genoa, Rozzano, Candiolo, Pisa, Bari, Brescia
2022-07-14
Active, closed
GlaxoSmithKline
Phase 3
163
Bari, Brescia, Florence, Milan, Pavia, Pisa, Roma, Torrette AN
2022-07-14
Recruiting
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
1,000
Legnano, Orbassano, Ancona, Bari, Bergamo, Brescia, Cagliari, Cosenza
2022-07-13
Recruiting
Azienda Ospedaliera di Padova
Observational
46
Bologna, Brescia, Florence, Genova, Padova, Roma
2022-07-01
Recruiting
Changing Paragidms In The Prognostic Assessment Of Hodgkin Lymphoma
NCT06822855Classical Hodgkin Lymphoma, Classical Hodgkin Lymphoma Recurrent, Classical Hodgkin Lymphoma Refractory
Azienda USL Reggio Emilia - IRCCS
Observational
755
Milan, Reggio Emilia, Avellino, Brescia, Padova, Palermo, Perugia, Piacenza
2022-06-23
Active, closed
Sanofi
Phase 3
531
Torette, Meldola, Rome, Bologna, Brescia, Pavia
2022-06-23
Active, closed
ADC Therapeutics S.A.
Phase 1
154
Bergamo, Bologna, Brescia, Milan
2022-06-17
Active, closed
Sanofi
Phase 2
48
Bologna, Rome, Brescia, Milan
2022-06-09
Recruiting
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
Phase 2
80
Brescia
2022-06-08
Recruiting
Pirfenidone to Prevent Fibrosis in Ards.
NCT05075161Acute Respiratory Distress Syndrome (ARDS)
DrugPirfenidone
Università Vita-Salute San Raffaele
Phase 3
130
Milan, Alessandria, Bari, Brescia, Cagliari, Merano, Palermo, Pisa
2022-06-01
Active, closed
Gilead Sciences
Phase 2
193
Brescia, Catania, Parma, Rome, Rozzano
2022-05-30
Recruiting
Bio-CAR-T BS Study
NCT05366569Diffuse Large B Cell Lymphoma (DLBCL), Primary Mediastinal Large B-cell Lymphoma (PMBCL), Acute Lymphoblastic Leukemia (ALL)
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
Observational
45
Brescia
2022-04-26
Active, closed
ARCAGY/ GINECO GROUP
Phase 3
260
Aviano, Bari, Biella, Brescia, Faenza, Lucca, Lugo, Milan
2022-04-15
Recruiting
Cogent Biosciences, Inc.
Phase 3
482
Aviano, Bologna, Brescia, Candiolo, Florence, Meldola, Milan, Palermo
2022-04-14
Recruiting
AstraZeneca
Phase 2
630
Aviano, Brescia, Catanzaro, Florence, Genova, Meldola, Milan, Monza
2022-04-14
Recruiting
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
NCT05131022Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Diffuse Large B Cell Lymphoma (DLBCL), Follicular Lymphoma (FL)
DrugBexobrutideg
Nurix Therapeutics, Inc.
Phase 1
572
Bologna, Brescia, Milan, Rome
2022-04-13
Active, closed
Protagonist Therapeutics, Inc.
Phase 3
293
Meldola, Bergamo, Bologna, Brescia, Florence, Milan, Pavia, Pesaro
2022-04-01
Active, closed
Gruppo Oncologico del Nord-Ovest
Phase 2
30
Brescia
2022-03-24
Active, closed
Fondazione Italiana Linfomi - ETS
Phase 2
49
Brescia, Alessandria, Cuneo, Florence, Genova, Milan, Naples, Novara
2022-03-21
Active, closed
Otsuka Pharmaceutical Development & Commercialization, Inc.
Phase 3
530
Bologna, Brescia, Florence, Genova, Messina, Milan, Naples, Pavia
2022-03-15
Recruiting
Hoffmann-La Roche
Phase 1
332
Brescia, Milan, Sant'Andrea Delle Fratte (PG)
2022-03-07
Recruiting
Pfizer
Phase 3
640
Bari, Brescia, Latina, Rome, Milan
2022-02-28
Active, closed
Unraveling the Role of Extracellular Vesicles-driven Senescence in Myeloproliferative Neoplasms
NCT06798805Essential Thrombocythemia (ET), Myelofibrosis (MF), Polycythemia Vera (PV)
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
110
Bologna, Brescia, Meldola, Ravenna, Reggio Emilia
2022-02-15
Recruiting
Meyer Children's Hospital IRCCS
Observational
290
Florence, Bari, Brescia, Catanzaro, Lecce, Milan, Padova, Pavia
2022-02-10
Active, closed
AstraZeneca
Phase 3
1,051
Brescia, Florence, Lucca, Meldola, Orbassano, Parma, Pavia, Roma
2022-02-07
Active, closed
Denali Therapeutics Inc.
Phase 1/2
85
Brescia, Florence, Milan, Tricase
2022-02-01
Recruiting
Mario Negri Institute for Pharmacological Research
Observational
2,500
Alessandria, Arezzo, Baggiovara, Bergamo, Bologna, Brescia, Cagliari, Correggio
2022-01-03
Active, closed
Washington University School of Medicine
Phase 2/3
197
Brescia, Florence
2021-12-22
Recruiting
Takeda
Phase 2
135
Bari, Bologna, Brescia, Florence, Genova, Milan, Reggio Emilia, Roma
2021-12-16
Active, closed
Merck Sharp & Dohme LLC
Phase 3
643
Bologna, Milan, Monza, Turin, Brescia
2021-12-13
Recruiting
Epidemiological Study on Invasive Bacterial Diseases
NCT06322290Invasive Bacterial Diseases (IBD)
Meyer Children's Hospital IRCCS
Observational
5,000
Adria, Ancona, Andria, Bari, Bologna, Brescia, Campobasso, Camposampiero
2021-12-09
Active, closed
Gruppo Italiano Malattie EMatologiche dell'Adulto
Phase 2
101
Alessandria, Ancona, Bari, Bergamo, Bologna, Brescia, Cagliari, Castelfranco Veneto
2021-12-03
Active, closed
Novartis Pharmaceuticals
Phase 3
17,004
Bologna, Brescia, Cona, Florence, Grosseto, Pozzilli, Milan, Rozzano
2021-11-23
Active, closed
Gilead Sciences
Phase 3
603
Bergamo, Brescia, Catania, Catanzaro, Cremona, Milan, Pavia, Roma
2021-11-17
Active, closed
Sirolimus-coated Balloon Versus Drug-eluting Stent in Native Coronary Vessels - TRANSFORM II
NCT04893291Coronary Artery Disease, Coronary Artery Stenosis
Fondazione Ricerca e Innovazione Cardiovascolare ETS
Not applicable
1,820
Aversa, Brescia, Genova, La Spezia, Milan, Paderno Dugnano, Palermo, Roma
2021-11-16
Active, closed
Camurus AB
Phase 3
332
Bari, Bologna, Brescia, Florence, Genova, Meldola, Milan, Modena
2021-10-22
Active, closed
International Extranodal Lymphoma Study Group (IELSG)
Phase 2
26
Brescia, Milan, Novara, Ravenna, Reggio Emilia, Varese
2021-10-20
Recruiting
Study on the Diagnosis and Management of CLL in Italy by GIMEMA
NCT04867915Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, MBL-CLL - Monoclonal B-Cell Lymphocytosis Chronic Lymphocytic Leukaemia-Type
Gruppo Italiano Malattie EMatologiche dell'Adulto
Observational
12,500
Alessandria, Brescia, Brindisi, Candiolo, Florence, Messina, Mestre, Milan
2021-10-13
Active, closed
Observational GORE® VIABAHN® Endoprosthesis With PROPATEN Bioactive Surface Global Registry
NCT04907240Peripheral Artery Disease, Popliteal Aneurysm, Hemodialysis Access, Visceral Artery Aneurysms
W.L.Gore & Associates
Observational
614
Ancona, Brescia, Modena, Torino, Varese
2021-10-09
Recruiting
Niguarda Hospital
Phase 3
288
Ancona, Bergamo, Bologna, Brescia, Cagliari, Chieti, Florence, Genova
2021-10-07
Recruiting
Marco Lorenzo Bonu
Phase 3
310
Brescia
2021-09-30
Active, closed
Loxo Oncology, Inc.
Phase 3
282
Rionero in Vulture, Bergamo, Brescia, Meldola, Milan, Monza, Novara, Perugia
2021-09-23
Active, closed
Sequential Treatment With Ponatinib and Blinatumomab vs Chemotherapy and Imatinib in Newly Diagnosed Adult Ph+ ALL
NCT04722848Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive), ALL, Adult, Philadelphia-Positive ALL
DrugsPonatinib·Imatinib·Blinatumomab
Gruppo Italiano Malattie EMatologiche dell'Adulto
Phase 3
236
Ascoli Piceno, Bari, Bergamo, Bolzano, Brescia, Mestre, Modena, Pagani
2021-09-08
Recruiting
Merck Sharp & Dohme LLC
Phase 2
355
Naples, Milan, Siena, Bologna, Brescia, Verona
2021-08-12
Recruiting
Genentech, Inc.
Phase 1
186
Bergamo, Brescia
2021-07-26
Active, closed
Boston Scientific Corporation
Not applicable
297
Brescia, Cotignola, Naples, Pisa
2021-07-20
Active, closed
Biogen
Phase 3
562
Rozzano, Scafati, Brescia, Padova, Pisa, Roma
2021-07-16
Recruiting
Meyer Children's Hospital IRCCS
Observational
103
Bergamo, Brescia, Florence, Genova, Milan, Palermo, Torino, Trieste
2021-07-13
Recruiting
Corcym S.r.l
Observational
2,150
Ancona, Bologna, Brescia, Lecce, Massa, Milan, Naples, Palermo
2021-06-29
Active, closed
Hoffmann-La Roche
Phase 3
142
Bari, Naples, Brescia, Monza, Turin
2021-06-25
Recruiting
Poor Grade Aneurysmal Subarachnoid Hemorrhage Study Group
NCT04945603Subarachnoid Hemorrhage, Aneurysmal, Poor Grade Subarachnoid Hemorrhage
IRCCS San Raffaele
Observational
800
Bergamo, Bologna, Brescia, Lecce, Milan, Novara, Parma, Roma
2021-05-25
Active, closed
Incyte Corporation
Phase 3
899
Bergamo, Brescia, Candiolo, Catania, Forlì, Genoa, Lecce, Milan
2021-05-11
Active, closed
Alfasigma S.p.A.
Observational
1,304
Bari, Brescia, Catania, Ferrara, Genova, Milan, Naples, Roma
2021-05-11
Active, closed
Hoffmann-La Roche
Observational
800
Taranto, Reggio Calabria, Meldola, Rome, Genoa, Brescia, Cremona, Novara
2021-05-10
Active, closed
Hoffmann-La Roche
Phase 2
586
Naples, Salerno, Bologna, Rome, Genoa, Brescia, Milan, Pozzilli (IS)
2021-05-05
Active, closed
Hoffmann-La Roche
Phase 3
1,188
Avellino, Naples, Modena, Aviano, Rome, Brescia, Milan, Livorno
2021-05-04
Active, closed
Ponatinib in Adult Ph+ ALL Patients With MRD Positivity or Hematological Relapse
NCT04475731Philadelphia-Positive ALL, Acute Lymphoblastic Leukemia, in Relapse
DrugPonatinib
Gruppo Italiano Malattie EMatologiche dell'Adulto
Phase 2
67
Ancona, Ascoli Piceno, Avellino, Bari, Bergamo, Bologna, Brescia, Cuneo
2021-05-04
Active, closed
Abbott Medical Devices
Observational
200
Ancona, Brescia, Pisa
2021-05-04
Recruiting
Ipsen
Phase 1/2
240
Brescia, Naples, Rome, Verona
2021-04-29
Active, closed
Phase 1/2 Study Evaluating MCLA-129, a Human Anti-EGFR, Anti-c-MET Bispecific Antibody, in Advanced NSCLC and Other Solid Tumors, Alone and in Combination
NCT04868877Non-Small Cell Lung Cancer Metastatic, Gastric Cancer, Esophageal Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma
DrugsBispecific·Tagrisso·Osimertinib
Merus B.V.
Phase 1/2
194
Roma, Bologna, Brescia, Milan, Orbassano, Salerno, Verona
2021-04-28
Active, closed
Incyte Corporation
Phase 3
654
Bari, Brescia, Candiolo, Catania, Lecce, Milan, Naples, Novara
2021-04-15
Active, closed
Eli Lilly and Company
Phase 3
101
Naples, Genoa, Milan, Florence, Brescia
2021-04-13
Active, closed
Phase 3 Study of Pelabresib (CPI-0610) in Myelofibrosis (MF) (MANIFEST-2)
NCT04603495Myelofibrosis, Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis
DrugsPelabresib·Ruxolitinib
Novartis Pharmaceuticals
Phase 3
430
Bergamo, Bologna, Brescia, Ferrara, Florence, Meldola, Milan, Monza
2021-04-09
Recruiting
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
NCT04728893Hematologic Malignancies, Waldenstroms Macroglobulinaemia, Non-Hodgkins Lymphoma, Chronic Lymphocytic Leukaemia
DrugNemtabrutinib
Merck Sharp & Dohme LLC
Phase 2
490
Bari, Bologna, Brescia, Milan, Naples, Pavia, Reggio Emilia, Roma
2021-04-05
Active, closed
Kedrion S.p.A.
Phase 3
30
Brescia, Florence, Genova, Milan, Naples, Roma
2021-03-31
Recruiting
Fondazione Italiana Linfomi - ETS
Phase 3
430
Brescia, Piacenza, Rionero in Vulture, Alessandria, Ancona, Ascoli Piceno, Aviano, Barletta
2021-03-23
Active, closed
Bristol-Myers Squibb
Phase 1/2
216
Bologna, Brescia, Florence, Verona
2021-03-22
Active, closed
Verici Dx
Observational
550
Bologna, Brescia
2021-03-21
Recruiting
Fondazione EMN Italy Onlus
Observational
1,900
Florence, Ancona, Bari, Bologna, Brescia, Catania, Genova, Milan
2021-03-16
Active, closed
Loxo Oncology, Inc.
Phase 3
238
Viale Orazio Flacco, Monza (MB) -Settore E, Pisa, Rionero in Vulture, Vicenza, Alessandria, Bergamo, Brescia
2021-03-09
Recruiting
Syndax Pharmaceuticals
Phase 2
296
Brescia, Milan, Monza, Pavia, Roma, Torino
2021-03-04
Active, closed
Celgene
Phase 3
313
Meldola (fc), Ancona, Bologna, Brescia, Catania, Florence, Milan, Napoli Campania
2021-02-25
Active, closed
Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation
NCT04699188KRAS G12C Mutant Solid Tumors, Carcinoma, Non-Small-Cell Lung, Carcinoma, Colorectal, Cancer of Lung
DrugsTNO155·Opnurasib·Tislelizumab
Novartis Pharmaceuticals
Phase 1/2
344
Brescia, Milan
2021-02-24
Recruiting
Treosulfan Therapeutic Drug Monitoring in Pediatric Hematopoietic Stem Cell Transplant Recipients
NCT06861257Pediatric Hematopoietic Stem Cell Transplantation, Malignant Disorders, Non-malignant Disorders
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
70
Bologna, Brescia, Genova, Milan, Monza, Padova, Pavia, Torino
2021-02-24
Active, closed
Mirati Therapeutics Inc.
Phase 3
453
Alessandria, Avellino, Aviano, Bari, Brescia, Candiolo, Catania, Florence
2021-02-23
Active, closed
Stichting European Myeloma Network
Phase 2
160
Ancona, Bologna, Bolzano, Brescia, Florence, Genova, Pavia, Terni
2021-02-22
Active, closed
Fondazione Melanoma Onlus
Phase 2
25
Bergamo, Bagno a Ripoli, Meldola, Milan, Naples, Padova, Brescia
2021-02-10
Recruiting
Centro Cardiologico Monzino
Observational
10,000
Milan, Ancona, Bari, Bergamo, Brescia, Foggia, Naples, Palermo
2021-02-10
Recruiting
Gruppo Oncologico del Nord-Ovest
Phase 2
49
Brescia
2021-02-08
Recruiting
AB Science
Phase 3
495
Baggiovara, Brescia, Gussago, Milan, Novara, Padova, Pavia, Torino
2021-02-02
Recruiting
Transcatheter Interventions for Tricuspid Insufficiency in Italy
NCT04735003Tricuspid Valve Insufficiency
Marianna Adamo
Observational
200
Brescia
2021-01-30
Active, closed
Hoffmann-La Roche
Phase 2
920
Rome, Brescia, Milan, Turin, Siena
2021-01-18
Active, closed
Genmab
Phase 3
483
Bari, Bergamo, Brescia, Meldola, Milan, Novara, Pavia, Ravenna
2021-01-13
Active, closed
Tailored Sonidegib Schedule After Complete Response in BCC
NCT04806646Locally Advanced Basal Cell Carcinoma
DrugSonidegib
Gruppo Oncologico del Nord-Ovest
Phase 2
21
Brescia
2021-01-12
Active, closed
Merck Sharp & Dohme LLC
Phase 3
990
Roma, Rome, Milan, Candiolo, Brescia, Naples, Padova
2021-01-10
Active, closed
BioNTech SE
Phase 2/3
358
Brescia, Legnago, Milan
2021-01-07
Active, closed
Amgen
Phase 1/2
181
Bergamo, Bologna, Brescia, Catania, Milan, Naples, Roma
2021-01-04
Active, closed
Pfizer
Phase 3
841
Monserrato (CA), San Giovanni Rotondo, Milan, Candiolo, Orbassano, Brescia, Naples, Padova
2020-12-21
Active, closed
Merck Sharp & Dohme LLC
Phase 3
672
Modena, Florence, Verona, Brescia, Milan, Padova, Roma
2020-12-08
Active, closed
Assessment of the Axone Micro Quadripolar Lead for Enhanced Cardiac Resynchronization Therapy
NCT04463641Heart Failure, Cardiac Resynchronization Therapy
MicroPort CRM
Not applicable
92
Brescia, Naples
2020-12-03
Recruiting
Mirati Therapeutics Inc.
Phase 2/3
626
Aviano, Bari, Bologna, Brescia, Candiolo, Florence, Genova, Meldola
2020-12-02
Recruiting
Gruppo Italiano Malattie EMatologiche dell'Adulto
Phase 3
274
Alessandria, Ancona, Ascoli Piceno, Bari, Bologna, Brescia, Brindisi, Castelfranco Veneto
2020-11-27
Active, closed
Safety and Efficacy Study of Epcoritamab in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia and Richter's Syndrome
NCT04623541Relapsed/Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Richter's Syndrome, Treatment-naïve High Risk Chronic Lymphocytic Leukemia
DrugsEpcoritamab·Pirtobrutinib·Lenalidomide·Venetoclax
Genmab
Phase 1/2
194
Bologna, Torino, Ferrara, Meldola, Rome, Roma, Brescia, Milan
2020-11-25
Active, closed
Alexion Pharmaceuticals, Inc.
Phase 3
281
Brescia
2020-11-03
Active, closed
Associazione Italiana per lo Studio del Pancreas
Phase 3
261
Aviano, Bari, Bergamo, Bologna, Brescia, Florence, Meldola, Milan
2020-11-03
Recruiting
CHoice of OptImal transCatheter trEatment for Mitral Insufficiency Registry
NCT04688190Mitral Regurgitation, Mitral Valve Disease, Mitral Annular Calcification
Universitätsklinikum Hamburg-Eppendorf
Observational
1,000
Brescia, Milan, Pisa
2020-11-01
Active, closed
Hoffmann-La Roche
Phase 3
992
Meldola, Rome, Brescia, Milan, Monza, Misterbianco (CT), Candiolo, Livorno
2020-10-09
Active, closed
AstraZeneca
Phase 3
370
Brescia, Candiolo, Florence, Milan, Modena, Naples, Padova
2020-10-02
Active, closed
European Myeloma Network B.V.
Phase 3
302
Ancona, Bari, Bologna, Brescia, Cuneo, Florence, Novara, Pavia
2020-09-25
Active, closed
argenx
Phase 2
229
Brescia, Florence, Genova, Messina, Milan, Pisa, Roma, Torino
2020-09-18
Active, closed
ADC Therapeutics S.A.
Phase 3
440
Udine, Brescia, Florence, Foggia, Meldola, Milan, Pavia, Ravenna
2020-09-16
Active, closed
Hoffmann-La Roche
Phase 3
271
Bari, Genoa, Brescia, Florence, Padova
2020-08-10
Recruiting
AutoInflammatory Disease Alliance Registry (AIDA)
NCT05200715Hereditary Autoinflammatory Diseases, Schnitzler Syndrome, Behcet Syndrome, PFAPA Syndrome
University of Siena
Observational
3,500
Siena, Bari, Bolzano, Brescia, Cagliari, Catania, Catanzaro, Chieti
2020-08-06
Active, closed
AstraZeneca
Phase 3
185
Ancona, Bologna, Brescia, Candiolo, Catania, Lecce, Lecco, Milan
2020-08-04
Recruiting
Societa Italiana di Dermatologia Medica, Chirurgica, Estetica e di Malattie Sessualmente Trasmesse
Observational
1,500
Brescia
2020-06-15
Active, closed
Epizyme, Inc.
Phase 3
599
Naples, Meldola, Brescia, Catania, Florence, Lecce, Milan, Monza
2020-06-11
Active, closed
GlaxoSmithKline
Phase 3
325
Bologna, Brescia, Catanzaro, Milan, Pavia, Perugia, Ravenna, Roma
2020-04-02
Recruiting
Covid-19 in Hematological Malignancies
NCT04733729COVID-19 Infection in Hematological Malignancies Patients
Sorveglianza Epidemiologica Infezioni Fungine Emopatie Maligne
Observational
3,000
Brescia, Naples, Rome, Varese, Verona
2020-03-01
Active, closed
Eli Lilly and Company
Phase 3
58
Brescia, Chieti, Genova, Milan, Naples, Palermo, Trieste
2020-02-12
Active, closed
Hoffmann-La Roche
Phase 2/3
325
Parma, Brescia, Milan, Bagno a Ripoli, Padova
2020-01-29
Recruiting
Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors
NCT03934372Acute Myeloid Leukemia, Accelerated Phase Chronic Myeloid Leukemia, Blast Phase Chronic Myeloid Leukemia, Chronic Phase Chronic Myeloid Leukemia
DrugPonatinib
Incyte Biosciences International Sàrl
Phase 1/2
70
Bologna, Brescia, Genova, Milan, Monza, Naples, Pavia, Rome
2020-01-29
Active, closed
Fitness in Elderly AML Patients
NCT07598838AML (Acute Myelogenous Leukemia
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
Observational
725
Brescia
2020-01-01
Recruiting
Sumitomo Pharma America, Inc.
Phase 1/2
240
Alessandria, Aviano, Bologna, Brescia, Meldola, Milan, Torino
2019-12-16
Active, closed
Cold Agglutinin Disease Real World Evidence Registry
NCT05791708Cold Agglutinin Disease (CAD), Cold Agglutinin Syndrome (CAS)
RECORDATI GROUP
Observational
429
Brescia, Campobasso, Novara, Palermo, Pavia, Ravenna, Reggio Calabria, Roma
2019-12-12
Active, closed
Gruppo Italiano Trapianto di Midollo Osseo
Phase 2
100
Brescia, San Giovanni Rotondo, Tricase, Monza, Ancona, Ascoli Piceno, Bari, Bologna
2019-12-09
Active, closed
Gruppo Italiano Trapianto di Midollo Osseo
Phase 2
120
Cagliari, Naples, Ancona, Bari, Bologna, Brescia, Cuneo, Florence
2019-12-06
Active, closed
Gilead Sciences
Phase 2/3
72
Bergamo, Brescia, Milan, Roma, Rome
2019-11-21
Active, closed
AbbVie
Phase 1
85
Rome, Brescia, Meldola
2019-11-08
Recruiting
High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)
NCT04221035High-Risk Neuroblastoma, Patient With Insufficient Response Chemoimmunotherapy
DrugsDinutuximab Beta·Vindesine·Cyclophosphamid·Thiotepa
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3
800
Bari, Brescia, Catania, Florence, Genova, Modena, Parma, Pavia
2019-11-05
Active, closed
Gruppo Italiano Malattie EMatologiche dell'Adulto
Phase 2
76
Ancona, Ascoli Piceno, Bergamo, Bologna, Bolzano, Brescia, Cuneo, Genova
2019-10-30
Active, closed
Niguarda Hospital
Phase 2
28
Alessandria, Bergamo, Bologna, Brescia, Milan, Novara, Pavia, Roma
2019-10-04
Active, closed
Celgene
Phase 1/2
424
Brescia, Milan, Reggio Emilia, Torino
2019-09-30
Active, closed
MALIBU Trial - Combination of Ibrutinib and Rituximab in Untreated Marginal Zone Lymphomas
NCT03697512Marginal Zone Lymphoma, Nodal Marginal Zone Lymphoma, Splenic Marginal Zone Lymphoma
DrugsIbrutinib·Rituximab
International Extranodal Lymphoma Study Group (IELSG)
Phase 2
175
Ponderano, Milan, Torino, Ancona, Bari, Brescia, Cagliari, Pavia
2019-09-27
Recruiting
National Database on Primary Biliary Cholangitis
NCT05151809Primary Biliary Cholangitis
University of Milano Bicocca
Observational
6,000
Ancona, Bari, Bergamo, Bologna, Bolzano, Brescia, Cagliari, Castellana Grotte
2019-09-19
Active, closed
GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors
NCT04083599Malignant Solid Tumor, Non-Small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC), Melanoma
DrugsGEN1042·Adrucil·Nab-paclitaxel·Pemetrexed
Genmab
Phase 1/2
350
Brescia, Cuneo, Milan, Rozzano
2019-09-17
Active, closed
Pfizer
Phase 3
896
Castellana Grotte, Brescia, Milan, San Donato Milanese, Rho, Modena, Florence, Negrar(vr)
2019-09-05
Not yet open
Hepatocarcinoma Recurrence on the Liver Study - Part2
NCT04053231Liver Cancer, Surgery, Recurrence Tumor, Cirrhosis
University of Milano Bicocca
Observational
3,000
Bari, Bologna, Bolzano, Brescia, Forlì, Lecco, Mantua, Milan
2019-09
Recruiting
University Hospital Muenster
Phase 3
683
Ancona, Bari, Bergamo, Bologna, Brescia, Cagliari, Catania, Cona
2019-08-23
Active, closed
Sanofi
Observational
1,860
Terracina, Naples, Padua, Bari, Bologna, Brescia, Catania, Milan
2019-08-15
Active, closed
Janssen Research & Development, LLC
Phase 2/3
118
Ascoli Piceno, Brescia, Catania, Florence, Milan, Monza, Novara, Roma
2019-08-15
Active, closed
OncoVerity, Inc.
Phase 2
103
Bologna, Brescia, Meldola, Milan, Naples, Udine
2019-07-29
Active, closed
Fondazione Italiana Linfomi - ETS
Phase 2
75
Castelfranco Veneto, Alessandria, Ancona, Avellino, Aviano, Bari, Brescia, Cagliari
2019-07-02
Active, closed
Fondazione EMN Italy Onlus
Phase 2
45
Ancona, Bari, Bergamo, Bologna, Brescia, Catania, Milan, Novara
2019-07-01
Active, closed
Fondazione EMN Italy Onlus
Phase 3
84
Alessandria, Ancona, Ascoli Piceno, Bari, Bergamo, Bolzano, Brescia, Cagliari
2019-07-01
Recruiting
European Organisation for Research and Treatment of Cancer - EORTC
Observational
2,000
Acquaviva delle Fonti, Arezzo, Brescia, Florence, Milan, Negrar, Pavia, Perugia
2019-06-24
Active, closed
Bristol-Myers Squibb
Phase 3
437
Brescia, Arezzo, Aviano (PN), Milan, Parma, Roma
2019-06-21
Active, closed
Janssen Research & Development, LLC
Phase 3
2,517
Abano Terme, Acquaviva delle Fonti, Bassano del Grappa, Brescia, Chieti, Florence, Milan, Modena
2019-06-11
Active, closed
Sanofi
Observational
955
Torrette Di Ancona, Terracina, Rome, Bari, Brescia, Cagliari, Genova, L’Aquila
2019-06-11
Active, closed
Regeneron Pharmaceuticals
Phase 3
415
Bergamo, Bologna, Brescia, Florence, L’Aquila, Milan, Naples, Rome
2019-06-04
Recruiting
Protocol ITANET - Registry
NCT04282083Gastro-entero Pancreatic Neuroendocrine Tumors
Italian Association Neuroendocrine Tumors
Observational
3,600
Rozzano, Peschiera del Garda, Ancona, Bari, Bologna, Bolzano, Brescia, Brindisi
2019-05-25
Active, closed
IDH1 (AG 120) Inhibitor in Patients With IDH1 Mutated Myelodysplastic Syndrome
NCT03503409Myelodysplastic Syndromes, Acute Myeloid Leukemia
DrugIvosidenib
Groupe Francophone des Myelodysplasies
Phase 2
68
Alessandria, Ancona, Bologna, Brescia, Florence, Genova, Lecce, Milan
2019-05-14
Active, closed
European Myeloma Network B.V.
Phase 2
401
Ancona, Bergamo, Bologna, Brescia, Catania, Genova, Milan, Novara
2019-04-16
Recruiting
Eli Lilly and Company
Phase 3
190
Brescia, Chieti, Genova, Milan, Naples, Palermo, Trieste
2019-04-05
Recruiting
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
NCT04075305Oncology, Breast Cancer, Prostate Cancer, Gynecologic Cancer
UMC Utrecht
Observational
8,000
Brescia, Negrar
2019-02-01
Active, closed
AstraZeneca
Phase 3
1,407
Brescia, Lecce, Lecco, Milan, Mirano, Naples, Reggio Calabria, Reggio Emilia
2019-01-04
Active, closed
W.L.Gore & Associates
Observational
280
Bologna, Brescia, Padova, Varese
2018-12-18
Active, closed
AstraZeneca
Phase 3
724
Arezzo, Brescia, Milan, Pisa
2018-11-30
Active, closed
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 2
58
Ancona, Bologna, Brescia, Roma, Torino
2018-11-19
Active, closed
AstraZeneca
Phase 3
730
Brescia, Milan, Orbassano, Parma, Roma, Rozzano, Terni
2018-09-27
Recruiting
Martin Schrappe
Phase 3
5,000
Ancona, Bari, Bergamo, Bologna, Brescia, Cagliari, Catania, Catanzaro
2018-07-15
Active, closed
Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors
NCT03485209Colorectal Neoplasms, Carcinoma, Non-Small-Cell Lung, Exocrine Pancreatic Cancer, Carcinoma, Squamous Cell of Head and Neck
DrugsTisotumab Vedotin·Tivdak·Keytruda·Cisplatin
Seagen, a wholly owned subsidiary of Pfizer
Phase 2
350
Meldola (Fc), Ravenna, Meldola (FC), Rome, Brescia, Milan, Cattolica, Rimini
2018-06-25
Active, closed
Exelixis
Phase 3
837
Tricase, Rozzano, Bologna, Brescia, Milan, Naples, Novara, Roma
2018-06-10
Recruiting
Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria
Not applicable
340
Alessandria, Forlì, Camposampiero, Negrar, Acquaviva delle Fonti, Biella, Brescia, Cremona
2018-06-05
Active, closed
Merck Sharp & Dohme LLC
Phase 3
797
Milano, Naples, Meldola, Rozzano, Milan, Monza, Orbassano, Brescia
2018-04-24
Active, closed
Janssen Research & Development, LLC
Phase 3
629
Alessandria, Arezzo, Aviano, Bergamo, Brescia, Cremona, Florence, Genova
2018-03-23
Active, closed
AstraZeneca
Phase 2
273
Ancona, Bologna, Brescia, Cona, Genova, Lecco, Meldola, Messina
2018-03-07
Recruiting
Randomization of Single vs Multiple Arterial Grafts
NCT03217006Coronary Artery Disease, Heart Diseases
Weill Medical College of Cornell University
Not applicable
4,300
Bari, Brescia, Cotignola, Roma, Rome, Torino
2018-01-07
Active, closed
Sanofi
Phase 3
475
Ancona, Bergamo, Bologna, Brescia, Torino
2017-12-07
Active, closed
Maastricht University Medical Center
Not applicable
250
Brescia, Milan, Rome
2017-11-01
Active, closed
BeiGene
Phase 3
590
Brescia, Meldola, Milan, Modena, Ravenna, Roma, Terni, Torino
2017-10-31
Active, closed
ViiV Healthcare
Phase 3
1,049
Brescia, Milan
2017-10-27
Active, closed
A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis
NCT03165734Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis
DrugPacritinib
Swedish Orphan Biovitrum
Phase 3
407
Bari, Bologna, Brescia, Florence, Forlì, Milan, Monza, Naples
2017-06-26
Rows per page Showing 1–500 of 522
1 2 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 9 October 2026. https://priyalifescience.com/clinical-trials-italy/city/brescia

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,778 studies in total at the last sync on 08 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 522 of those studies with a site in Brescia.

How many clinical trials are recruiting in Brescia?

291 of the 522 studies on this page are recruiting new participants as of the 08 Oct 2026, 03:19 UTC sync. A further 21 have not yet opened recruitment, 209 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Brescia), 522 studies
PhaseStudiesRecruitingShare
Phase 321610741.4%
Observational1269124.1%
Phase 2823815.7%
Not applicable41307.9%
Phase 1/22083.8%
Phase 2/319113.6%
Phase 11041.9%
Phase 4821.5%

Most active sponsors

Lead sponsors with the most studies (Brescia)
Lead sponsorStudiesRecruiting
AstraZeneca2714
Fondazione Italiana Linfomi - ETS2514
Novartis Pharmaceuticals2110
Hoffmann-La Roche187
Merck Sharp & Dohme LLC169
Janssen Research & Development, LLC148
IRCCS Centro San Giovanni di Dio Fatebenefratelli1210
Bristol-Myers Squibb105
Incyte Corporation106
Sanofi104
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.